Real-world treatment outcomes and safety of natalizumab in Finnish multiple sclerosis patients

OBJECTIVES: The primary objective was to evaluate long-term treatment persistence and safety of natalizumab in Finnish multiple sclerosis patients. The secondary objectives were to assess patient characteristics, use of natalizumab-related safety protocol, and treatment persistence in patients with...

Descripción completa

Detalles Bibliográficos
Autores principales: Verkkoniemi-Ahola, Auli, Hartikainen, Päivi, Hassi, Katja, Kuusisto, Hanna, Lahdenperä, Sanni, Mehtälä, Juha, Viitala, Matias, Ylisaukko-oja, Tero, Soilu-Hänninen, Merja
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2023
Materias:
Original Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10552456/
https://www.ncbi.nlm.nih.gov/pubmed/37808458
http://dx.doi.org/10.1177/20552173231204466

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10552456/
https://www.ncbi.nlm.nih.gov/pubmed/37808458
http://dx.doi.org/10.1177/20552173231204466

Ejemplares similares